entity

Methylation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Methylation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

5Connections
24Hypotheses
0Analyses
3Outgoing
2Incoming
12Experiments
0Debates

No AI portrait yet

Wiki Pages (9)

Knowledge base pages for this entity

Validated Hypothesis: p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance

hypothesis · 4763 words

Tau Pathology Alters Oligodendrocyte Gene Methylation in [Alzheimer's Disease](/diseases/alzheimers-disease)

mechanism · 3013 words

Alzheimer's Disease Histone Methylation and Epigenetic Writer Companies

company · 1405 words

DNA Methylation

entity · 1249 words

DNA Methylation in Neurodegeneration

mechanism · 1244 words

Outgoing (3)

TargetRelationTypeStr
HPA Axisregulatespathway0.90
HPA AXIS RELATED GENESmodulatesgene0.90
Epigenomic Reconfigurationcomponent_ofprocess0.85

Incoming (2)

SourceRelationTypeStr
C9orf72 Repeat Expansionassociated_withbiomarker0.90
PROTEIN ARGININE METHYLTRANSFERASEScatalyzesenzyme0.90

Targeting Hypotheses (24)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph 0.895 neurodegeneration What is the therapeutic window between i
TET2-Mediated Demethylation Rejuvenation Therapy 0.706 neurodegeneration Epigenetic clocks and biological aging i
Arginine Methylation Loss on FUS RGG Domains Drives Irrevers 0.680 als Biophysical Determinants Shifting FUS/TD
m6A Hypermethylation of SNCA mRNA Stabilises Alpha-Synuclein 0.662 parkinson m6A RNA Modification and Alpha-Synuclein
Temporal TET2-Mediated Hydroxymethylation Cycling 0.657 neurodegeneration Epigenetic reprogramming in aging neuron
Arginine Methylation Enhancement Therapy 0.653 neurodegeneration TDP-43 phase separation therapeutics for
CX3CR1 Promoter Methylation Disrupts Neuron-Microglia Cross- 0.649 developmental-neurobiology Do perinatal immune challenges create pe
Neuronal TET1 Upregulation Reactivates Immediate-Early Genes 0.640 neurodegeneration epigenetic reprogramming aging neurons
TREM2 Promoter Silencing via DNA Hypermethylation 0.576 developmental-neurobiology Do perinatal immune challenges create pe
Targeted DNA Demethylation at the Klotho Locus via dCas9-TET 0.510 neurodegeneration epigenetic reprogramming aging neurons
DNA Methylation Clock Drift at Glial Promoters 0.480 neurodegeneration Comparative epigenetic signatures: DNA m
DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Sca 0.460 neurodegeneration Investigate mechanisms of epigenetic rep
DNA Hypomethylation at P2RY12 Promoter Correlates with Disea 0.440 neurodegeneration What determines P2RY12 receptor expressi
Small-Molecule Modulation of G3BP1 Condensate Dynamics via P 0.400 neurodegeneration How do disease-associated mutations in G
DNMT1 Downregulation to Correct Genome-Wide Hypomethylation 0.380 neurodegeneration Comparative epigenetic signatures across
TET Enzyme Enhancement to Prevent Aberrant DNA Methylation 0.350 neurodegeneration Comparative epigenetic signatures across
Autophagy-Epigenetic Feedback Loop Creates a Compounding Bio 0.347 - Epigenetic clocks as biomarkers for Alzh
protective chromatin remodeling defines the therapeutic wind 0.345 neurodegeneration Are DNA methylation changes in neurodege
age-linked CpG drift is the actionable driver in: Are DNA me 0.344 neurodegeneration Are DNA methylation changes in neurodege
age-linked CpG drift is the actionable driver in: Are age-re 0.344 neurodegeneration Are age-related DNA methylation changes
ATAC-seq accessibility separates causal from compensatory st 0.342 neurodegeneration Are DNA methylation changes in neurodege
ATAC-seq accessibility separates causal from compensatory st 0.327 neurodegeneration Are age-related DNA methylation changes
protective chromatin remodeling defines the therapeutic wind 0.326 neurodegeneration Are age-related DNA methylation changes
Epigenetic Clock Reversal Through Targeted DNA Demethylation 0.000 - Epigenetic clocks and biological aging i

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (12)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
MAPK pathway inhibition by QTJD through butyrate mechanism exploratory Mycoplasma pneumoniae pneumoni 0.900 0.00 Mouse macrophages proposed N/A
Tet2 modulation in Aβ42-injured mouse hippocampal neurons exploratory Alzheimer's disease 0.900 0.00 primary mouse hippocampal neur proposed N/A
AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral study validation Alzheimer's disease 0.900 0.00 young APPswe/PSEN1 double-tran proposed N/A
Network pharmacology screening of ginger targets against gastric cance exploratory gastric cancer 0.900 0.00 computational analysis using h proposed N/A
Tet2 expression analysis in aged 2×Tg-AD mouse brains exploratory Alzheimer's disease 0.850 0.00 APPswe/PSEN1 double-transgenic proposed N/A
Molecular docking validation of ginger-PRMT1 interactions exploratory gastric cancer 0.800 0.00 computational molecular dockin proposed N/A
Proposed experiment from debate on Epigenetic clocks and biological ag falsification Neurodegeneration 0.400 0.50 mouse completed $450,000
DNA Damage Repair Deficiency Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human completed $7,500,000
Epigenetic Clocks in Neurodegeneration — Causal Drivers or Passive Mar validation Neurodegeneration 0.400 0.50 human completed $3,000,000
Epigenetic Dysregulation Validation in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,500,000
Epigenetic Regulation Dysfunction in Alzheimer's and Parkinson's Disea clinical Alzheimer's Disease 0.400 0.50 human proposed $7,500,000
LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Never Develo validation Parkinson's Disease 0.400 0.50 human completed $2,730,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Predicting the molecular mechanism of ginger targeting PRMT1/BTG2 axis to inhibi [PMID:40446574] Chen G, Gou B, Du Y, Zhou Z, Bai Y, Yang Phytomedicine 2025 1
PRMT1 promotes pancreatic cancer development and resistance to chemotherapy. [PMID:38460517] Ku B, Eisenbarth D, Baek S, Jeong TK, Ka Cell Rep Med 2024 1
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemor [PMID:38383964] Yamamoto T, Hayashida T, Masugi Y, Oshik Cancer Res 2024 1
Promising role of protein arginine methyltransferases in overcoming anti-cancer [PMID:37980859] Zhu Y, Xia T, Chen DQ, Xiong X, Shi L, Z Drug Resist Updat 2024 1
Protein arginine methylation: from enigmatic functions to therapeutic targeting. [PMID:33742187] Wu Q, Schapira M, Arrowsmith CH, Barsyte Nat Rev Drug Discov 2021 1
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. [PMID:33398264] Turner JS, Kim W, Kalaidina E, Goss CW, Res Sq 2020 1
Reply to Rosen: Temperature-growth relationship is robust. [PMID:31375623] Diffenbaugh NS, Burke M Proc Natl Acad Sci U S A 2019 1
Cryo-electron microscopy structures of human oligosaccharyltransferase complexes [PMID:31831667] Ramírez AS, Kowal J, Locher KP Science 2019 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with [PMID:28068668] Britschgi A, Duss S, Kim S, Couto JP, Br Nature 2017 1
CD161 defines a transcriptional and functional phenotype across distinct human T [PMID:25437561] Fergusson JR, Smith KE, Fleming VM, Rajo Cell Rep 2014 1
Genome-wide methylation profiles reveal quantitative views of human aging rates. [PMID:23177740] Hannum G, Guinney J, Zhao L, Zhang L, Hu Mol Cell 2013 1
Tet methylcytosine dioxygenase 2(TET2)-dependent epigenetic regulation in the pa [PMID:41811389] Liu K, Hong Y, Gao Q, Huang J, Liu L, Li Cellular and molecular life sc 2026 0
Repression of PRMT activities sensitize human homologous recombination-proficien [PMID:41632514] ["Zhang Y", "Xu M", "Yuan J", "Hu Z", "J eLife 2026 0
IRG1-itaconate axis in immunometabolism: mechanistic roles and therapeutic poten [PMID:41743716] Liu Y, Zhang P, Kong W, Li J, Yang H, Ba Frontiers in immunology 2026 0
Ginsenoside RG3 and cantharidin synergistically suppress the progression of hepa [PMID:41501793] ["Wang Y", "Yuan H", "Yu Y", "Gou X", "W Journal of translational medic 2026 0
DNA Methylation in the Ovary and Uterus of Mammalian Animal Models: Implications [PMID:41751612] Serej O, Kowalik MK, Rekawiecki R Genes 2026 0
Promoter demethylation and protein O-GlcNAcylation-mediated enhancement of fatty [PMID:41360204] Lin ZH, Chou PI, Chang JW, Lin ZC, Sun Y J Nutr Biochem 2026 0
Protein arginine methyltransferases in cancer: mechanisms, functions, and therap [PMID:41928257] Jeong Y, Cho Y, Kim YK J Biomed Sci 2026 0
Tet2-driven clonal hematopoiesis drives aortic aneurysm via macrophage-to-osteoc [PMID:41739588] Yonekawa J, Yura Y, Luo J, Kato K, Ikeda The Journal of clinical invest 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning Methylation in their description or question text

Arginine Methylation Enhancement Therapy

Score: 0.653 · neurodegeneration · 2026-04-02

## Molecular Mechanism and Rationale The TAR DNA-binding protein 43 (TDP-43) has emerged as a central pathological play

CX3CR1 Promoter Methylation Disrupts Neuron-Microglia Cross-Talk

Score: 0.649 · developmental-neurobiology · 2026-04-21

## **Molecular Mechanism and Rationale** The CX3CR1-mediated fractalkine signaling pathway represents a critical regula

Neuronal TET1 Upregulation Reactivates Immediate-Early Genes and Restores Dendri

Score: 0.640 · neurodegeneration · 2026-04-22

**Molecular Mechanism and Rationale** The hypothesis centers on the ten-eleven translocation 1 (TET1) enzyme's critical

TREM2 Promoter Silencing via DNA Hypermethylation

Score: 0.576 · developmental-neurobiology · 2026-04-21

**Molecular Mechanism and Rationale** The proposed hypothesis centers on the epigenetic silencing of TREM2 (Triggering

Targeted DNA Demethylation at the Klotho Locus via dCas9-TET1 Rescues Neuroprote

Score: 0.510 · neurodegeneration · 2026-04-22

## Mechanistic Overview Targeted DNA Demethylation at the Klotho Locus via dCas9-TET1 Rescues Neuroprotective Klotho Exp

DNA Methylation Clock Drift at Glial Promoters

Score: 0.480 · neurodegeneration · 2026-04-25

DNA Methylation Clock Drift at Glial Promoters

DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Scars' at Polycomb Targ

Score: 0.460 · neurodegeneration · 2026-04-21

## Mechanistic Overview DNMT3A-Mediated de novo Methylation Corrects 'Epigenetic Scars' at Polycomb Targets starts from

DNA Hypomethylation at P2RY12 Promoter Correlates with Disease Progression

Score: 0.440 · neurodegeneration · 2026-04-21

## Mechanistic Overview DNA Hypomethylation at P2RY12 Promoter Correlates with Disease Progression starts from the claim

Small-Molecule Modulation of G3BP1 Condensate Dynamics via PRMT1 Methylation as

Score: 0.400 · neurodegeneration · 2026-04-22

## Mechanistic Overview Small-Molecule Modulation of G3BP1 Condensate Dynamics via PRMT1 Methylation as a Therapeutic St

DNMT1 Downregulation to Correct Genome-Wide Hypomethylation

Score: 0.380 · neurodegeneration · 2026-04-25

DNMT1 Downregulation to Correct Genome-Wide Hypomethylation

TET Enzyme Enhancement to Prevent Aberrant DNA Methylation

Score: 0.350 · neurodegeneration · 2026-04-25

TET Enzyme Enhancement to Prevent Aberrant DNA Methylation

Autophagy-Epigenetic Feedback Loop Creates a Compounding Biomarker Signal — Auto

Score: 0.347 · unknown disease · 2026-04-25

Concise Statement: Progressive failure of autophagy flux in AD neurons produces a cascading epigenetic feedback loop —

protective chromatin remodeling defines the therapeutic window for: Are DNA meth

Score: 0.345 · neurodegeneration · 2026-04-26

The same signal may be beneficial early and damaging late. Testing protective chromatin remodeling with single-cell meth

age-linked CpG drift is the actionable driver in: Are DNA methylation changes in

Score: 0.344 · neurodegeneration · 2026-04-26

The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, p

age-linked CpG drift is the actionable driver in: Are age-related DNA methylatio

Score: 0.344 · neurodegeneration · 2026-04-26

The gap can be tested by treating age-linked CpG drift as an upstream driver rather than a passive correlate. If true, p